Success Metrics

Clinical Success Rate
94.4%

Based on 17 completed trials

Completion Rate
94%(17/18)
Active Trials
14(34%)
Results Posted
0%(0 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_4
2
5%
Ph not_applicable
22
54%
Ph phase_1
1
2%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution25 total trials
Phase 1Safety & dosage
1(4.0%)
Phase 4Post-market surveillance
2(8.0%)
N/ANon-phased studies
22(88.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.4%

17 of 18 finished

Non-Completion Rate

5.6%

1 ended early

Currently Active

14

trials recruiting

Total Trials

41

all time

Status Distribution
Active(17)
Completed(17)
Terminated(1)
Other(6)

Detailed Status

Completed17
Recruiting13
unknown6
Not yet recruiting3
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
41
Active
14
Success Rate
94.4%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (4.0%)
Phase 42 (8.0%)
N/A22 (88.0%)

Trials by Status

not_yet_recruiting37%
active_not_recruiting12%
recruiting1332%
completed1741%
terminated12%
unknown615%

Recent Activity

Clinical Trials (41)

Showing 20 of 41 trialsScroll for more
NCT06242509

Intestinal Akkermansia Muciniphila in Prostate Cancer

Recruiting
NCT06907095Not Applicable

Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals

Recruiting
NCT05658471Not Applicable

Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)

Completed
NCT01648855

Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn

Completed
NCT07470541Not Applicable

Viromes in Infants Presenting With a Septic Syndrome

Not Yet Recruiting
NCT02840058Not Applicable

Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1

Completed
NCT06600295

Oncology, Undernutrition and Sensoriality: Links, Mechanisms and Levers for Action

Recruiting
NCT07417085Not Applicable

MICRO-BRAIN 2024: Study on Pediatric Brain Tumors

Recruiting
NCT07402200Not Applicable

Study of Indoor Air Pollutants and Their Impact in Children's Health and Wellbeing

Recruiting
NCT01340222Not Applicable

Monocyte Chemotactic Protein-1 (MCP-1) Expressing Monocytes to Predict Preterm Delivery: PhenoMAP Study

Completed
NCT02719951Phase 1

Glutaminergic Transmission in Autism : Molecular Imaging Exploration

Completed
NCT06824779Phase 4

Impact of FLU Vaccination on Nasal Resident Memory Immune Responses and Peripheral Respiratory-tropic Memory Immune Responses

Active Not Recruiting
NCT04952766Phase 4

Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

Completed
NCT06235580

Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions

Recruiting
NCT05787795

Identifying and Characterizing Preclinical MS

Recruiting
NCT07119086Not Applicable

Factors Associated With Hospitalization and Severity of Arbovirosis in the Indian Ocean

Recruiting
NCT06077097

Traumatic Events in Childhood, Attachment, Pain Perception, Epigenetic Marks, Quality of Life and Resilience.

Completed
NCT04024774

Diagnostic Research in Patients With Rare Diseases -Solving the Unsolved Rare Diseases

Recruiting
NCT06857604Not Applicable

The Interplay Between Inborn Error of Immunity and Blood Disorders: Unravelling Immune Defects Behind Common Haematological Diseases

Recruiting
NCT03117946Not Applicable

Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy

Recruiting

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
41